Clinical Utility of Metal Nanoparticle Solutions Against Multidrug-Resistant Pathogens
Researchers evaluated the antimicrobial activity of metal nanoparticles against several multidrug-resistant pathogens.
All articles by Jessica Nye, PhD
Bacille Calmette-Guérin Revaccination Is Safe During COVID-19 Convalescence
Researchers assessed the safety and efficacy of repeat bacille Calmette-Guérin vaccination among adults during the convalescent period of COVID-19 infection.
Fatty Liver Disease Prevalent in Patients With Chronic Hepatitis B Virus
Researchers assessed whether chronic hepatitis B virus infection is associated with an increased risk for fatty liver disease.
Ebola Reduces Visual Quality of Life in Pediatric Patients
Both children infected and their parents or caretakers demonstrated a significantly lowered emotional functioning, researchers report.
Fasting Blood Glucose Linked to Mortality Outcomes in Patients With COVID-19
Researchers assessed the relationship between fasting blood glucose levels and the risk of mortality in patients hospitalized with COVID-19.
Hepatitis C Virus Reinfection Risk After Successful Therapy in HIV-Positive Patients
Researchers assessed the risk for hepatitis C virus reinfection following successful therapy among different populations with HIV infection, including men who have sex with men.
New or Worsening Neurologic Symptoms After COVID-19 in Patients With Multiple Sclerosis
In a retrospective review, researchers sought to investigate the neurologic outcomes in patients with MS and related disorders following COVID-19 infection.
Outcomes of Trimer 4571 Vaccination Support Further Development of HIV Vaccine
Researchers assessed the safety and immunogenicity of the HIV-1 vaccine Trimer 4571 in HIV-negative adults.
Tafenoquine May Improve Clinical Recovery Time for Patients With COVID-19
Researchers assessed the efficacy of tafenoquine for the treatment of mild to moderate COVID-19 infection.
Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Patients With vs Without HIV
Researchers assessed humoral responses to COVID-19 vaccination with NVX-CoV2373 among patients with vs without HIV infection on the basis of prior COVID-19 exposure.
- Loading...
Loading...
Next post in HIV/AIDS
Loading... 
Loading...